Enhancing the QUAlity and Transparency Of health Research

EQUATOR resources in German | Portuguese | Spanish

STARD 2015 update for reporting diagnostic accuracy studies published

28/10/2015

stardThe STARD group, an international group of scientists, journal editors, funders, journalists, and other stakeholders, has developed an updated list of items that should be included in every diagnostic accuracy study report. The STARD 2015 reporting guideline update has been published simultaneously in the British Medical Journal, Radiology, and Clinical Chemistry.

Patrick Bossuyt who led the development of the first STARD reporting guideline in 2003 and this new update STARD 2015 states “with this STARD 2015 list, reports of studies that have evaluated the performance of medical tests will be more informative, more transparent, and more helpful to clinicians and others that have to decide whether or not to order, recommend, or reimburse this test. This will benefit us all: as scientists, both also as patients, and as payers. Testing is not always helpful, it can also be useless, and even be harmful. Incomplete study reports can do harm, and they can lead to a waste of valuable resources”.

To access the updated reporting guideline and the checklist and flow diagram please visit: STARD 2015

 

References
Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L, LijmerJG Moher D, Rennie D, de Vet HCW, Kressel HY, Rifai N, Golub RM, Altman DG, Hooft L, Korevaar DA, Cohen JF, For the STARD Group. STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies.

BMJ 2015;351:h5527
Radiology 2015,10.1148/radiol.2015151516
Clinical Chemistry 2015, doi:10.1373/clinchem.2015.246280

 

News archive

Email newsletter

Newsletter archive

Please complete the form below to sign up to receive our newsletters (view our privacy and data protection policy notice)

* indicates required

Latest guest blogger

  • Why did we develop TIDieR-Placebo?

    The TIDieR reporting guideline helps authors fully report their interventions, so that they can be used by others. However, TIDieR only explicitly covers active interventions, not placebo controls. The developers of the new TIDieR-Placebo extension explain why it is needed Read More